1. Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study. (February 2022) Authors: Danese, Silvio; Colombel, Jean-Frederic; Lukas, Milan; Gisbert, Javier P; D'Haens, Geert; Hayee, Bu'hussain; Panaccione, Remo; Kim, Hyun-Soo; Reinisch, Walter; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Tang, Meina Tao; Schreiber, Stefan; Aboo, Nazimuddin; ... Journal: Lancet gastroenterology and hepatology Issue: Volume 7:Number 2(2022) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Interleukin-4 receptor −3223C→T Polymorphism is Associated with Increased Gastric Adenocarcinoma Risk. (2012) Authors: Burada, Florin; Angelescu, Cristina; Mitrut, Paul; Ciurea, Tudorel; Cruce, Mihai; Saftoiu, Adrian; Ioana, Mihai Journal: Canadian Journal of Gastroenterology Issue: Volume 26:Number 8(2012) Page Start: 532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L‐PLUS 2). Issue 4 (15th March 2019) Authors: Peck‐Radosavljevic, Markus; Simon, Krzysztof; Iacobellis, Angelo; Hassanein, Tarek; Kayali, Zeid; Tran, Albert; Makara, Mihaly; Ben Ari, Ziv; Braun, Marius; Mitrut, Paul; Yang, Sheng‐Shun; Akdogan, Meral; Pirisi, Mario; Duggal, Ajay; Ochiai, Toshimitsu; Motomiya, Tomoko; Kano, Takeshi; Nagata, Ts... Journal: Hepatology Issue: Volume 70:Issue 4(2019) Page Start: 1336 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗